Edition:
United Kingdom

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

66.20CHF
3:41pm BST
Change (% chg)

CHF0.15 (+0.23%)
Prev Close
CHF66.05
Open
CHF66.05
Day's High
CHF66.55
Day's Low
CHF65.90
Volume
37,551
Avg. Vol
72,074
52-wk High
CHF74.00
52-wk Low
CHF58.45

Chart for

About

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s... (more)

Overall

Beta: 1.16
Market Cap(Mil.): CHF3,731.19
Shares Outstanding(Mil.): 55.40
Dividend: 2.75
Yield (%): 4.08

Financials

  BION.S Industry Sector
P/E (TTM): 4.38 85.68 32.76
EPS (TTM): 15.37 -- --
ROI: 28.44 1.78 14.61
ROE: 28.44 3.28 16.33

BRIEF-BB Biotech Q2 Net Result Swings To Loss Of CHF 98 Mln

* Q2 NET LOSS OF CHF 98 MN. VERSUS NET PROFIT OF CHF 103 MN REPORTED FOR Q2 OF 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

20 Jul 2018

BRIEF-BB Biotech H1 Loss At Around CHF 70 Mln

* H1 LOSS OF AROUND CHF 70 MLN (CHF 478.4 MLN PROFIT IN CORRESPONDING PERIOD OF PREVIOUS YEAR) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

12 Jul 2018

BRIEF-BB Biotech Q1 Profit Of CHF 28 Mln

* DGAP-ADHOC: BB BIOTECH SHARE GAINS VALUE IN FIRST QUARTER 2018 - SEVERAL LARGE-CAP BIOTECH COMPANIES TRADING AT WELL BELOW FUNDAMENTAL VALUE

20 Apr 2018

Earnings vs. Estimates